LNSR.US LENSAR Inc

Healthcare Health Care Equipment & Supplies USA Stocks
5.00 USD
Close of Nov 15, 2026
4.30 12.94
Market cap
USD 61.5M
P/E
11.4x
P/B
5.55x
ROE
423.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is LNSR.US undervalued?

Graham number
Price5.00
Graham value2.99
Premium67.5%

LNSR.US trades 67.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LENSAR Inc fundamental analysis

No fundamental analysis for LENSAR Inc yet.

LENSAR Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LENSAR Inc

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, p…

Full company profile